Friday, July 31, 2026

Didier Dubot Strengthens Premium Strategy, Expands Global Presence in the United States and Asia

Didier Dubot accelerates global expansion, focusing on online platforms and high-end products, achieving significant sales growth in Asia.

Park Bom’s Stunning Bare-Faced Selfie Leaves Fans in Awe

Park Bom from 2NE1 posted a stunning selfie on Instagram, highlighting her flawless skin and doll-like beauty, receiving admiration.

Coupang’s Testimony: How Will It Impact U.S.-Korea Trade Relations?

Coupang's interim CEO testifies before U.S. Congress amid trade tensions with South Korea, raising concerns about discrimination against U.S. firms.

Tag: lung cancer

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

GIST Maps Out the Cascade of Cellular Interactions During Early Stages of Lung Cancer

South Korean researchers unveil how mutated cells create a cancer-friendly environment in early lung cancer, paving the way for early interventions.

Stage 3 lung cancer patients over 70 can receive “active treatment” so “should not give up”

A study shows elderly patients (70+) with stage 3 lung cancer can complete standard treatment, challenging age-related treatment hesitance.

Is Your Cough a Warning Sign? Understanding Small Cell Lung Cancer and Its Treatment Advances

Lung cancer often shows no clear symptoms early on, making late detection common despite persistent cough or phlegm.

NCCN Endorses Leclaza and Rybrevant Combo as Top Lung Cancer Treatment: What You Need to Know

NCCN guidelines now classify Leclaza + Rybrevant as a preferred first-line treatment for lung cancer, enhancing patient access and management.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Cigarettes vs. DNA: Study Shows Smoking Is the Real Cancer Trigger

A study shows that smoking for over 20 years increases small-cell lung cancer risk by 54 times, highlighting smoking's dangers.

Tumors Shrinking, Hopes Rising: Voronoi’s VRN11 Shows Over 40% Tumor Reduction in Early Lung Cancer Trial

Voronoi's VRN11 shows promising anti-cancer efficacy in early trials, reducing tumors in resistant lung cancer patients without major side effects.

New South Korean Tech Detects Lung Cancer Early with Only 5 Drops of Blood

A South Korean team developed a blood test for early lung cancer detection, achieving 100% accuracy in identifying key mutations.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.